U.S. market Closed. Opens in 21 hours 53 minutes

HSCSW | Heart Test Laboratories, Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for HSCSW we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is weak.

Valuation (12%)

Company Industry
P/E Ratio (TTM) -326.46 48.08
PEG Ratio (TTM) -10.82 -0.81
P/S Ratio (TTM) 0.15 6.09
P/B Ratio (TTM) 401.06 6.08
P/FCF Ratio (TTM) -0.41 42.18
Price to 5YR AVG Earnings Ratio N/A 59.75
Price to 5YR AVG FCF Ratio N/A 34.18

Profitability (0%)

Company Industry
ROA (TTM) -89.00% 5.33%
ROE (TTM) -144.11% 27.92%
Net Profit Margin (TTM) -39.19% 7.77%
ROIC 5YR AVG N/A 6.77%

Growth (17%)

4QTR AVG 3YR AVG 5YR AVG
EPS 18.54% -1,473.40% N/A
Revenue 44.23% -56.05% N/A
Net Income -11.34% -3,555.53% N/A
Cash Flow -22.55% -23.63% N/A

Health (49%)

Company Industry
Current Ratio (TTM) 4.49 2.88
Quick Ratio (TTM) 4.02 2.15
D/E Ratio (TTM) 0.17 0.62
Interest Coverage (TTM) -20.72 23.04
Piotroski F-Score 5 6
Altman Z-Score N/A 7.61
LTL to 5YR AVG FCF N/A 3.48
Shares Outstanding Growth 5YR AVG N/A 1.62%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙